(Q39913316)

English

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

phase I clinical trial

0 references

phase II clinical trial

0 references

influenza vaccine

1 reference

based on heuristic

inferred from title

Emanuele Montomoli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

N Groth

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C Gentile

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

I Manini

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

R Bugarini

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

A Podda

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

0 references

publication date

21 November 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

786-791

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19027046%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Mortality associated with influenza and respiratory syncytial virus in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Influenza. The role of burden-of-illness research

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Medical economics in the field of influenza--past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Influenza vaccine--outmaneuvering antigenic shift and drift

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Epidemiology and pathogenesis of influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Development of a mammalian cell (Vero) derived candidate influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Quantitation and analysis of the specificity of post-immunization antibodies to influenza B viruses using single radial haemolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39913316&oldid=1973817115"